AirSculpt Announces Closing of Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional Shares

Core Viewpoint - AirSculpt Technologies, Inc. has successfully closed a public offering of 3,160,000 shares of common stock, with an additional 474,000 shares purchased by the underwriter, resulting in estimated proceeds of approximately $13.8 million after expenses [1][2]. Group 1: Offering Details - The public offering was underwritten by Leerink Partners, who acted as the sole bookrunner [2]. - The majority of the net proceeds from the offering will be used for prepaying a portion of the Company's outstanding debt under its existing credit agreement, while the remainder will be allocated for general corporate purposes, including working capital and other business opportunities [2]. Group 2: Regulatory Information - A shelf registration statement for the shares was filed with the Securities and Exchange Commission (SEC) and became effective on March 24, 2025 [3]. - A final prospectus supplement and accompanying prospectus related to the offering have been filed with the SEC and are accessible on the SEC's website [3]. Group 3: Company Overview - AirSculpt is a provider of next-generation body contouring treatments, focusing on comfort and precision, with procedures designed to remove fat and tighten skin while allowing for quick healing and minimal bruising [5].